In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection1* The annual RSV burden among US adults aged 18–49 years is about 17,000 hospitalizations, 277 ...
In the US, an estimated 21 million adults under 50 have at least one risk factor for severe RSV infection1* GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results